VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.47 USD | +0.21% |
|
-0.49% | -2.75% |
| May. 20 | BMO Capital Adjusts Ventas Price Target to $53 From $51 | MT |
| May. 16 | Scotiabank Adjusts Price Target on Ventas to $51 From $47 | MT |
Financials (USD)
| Sales 2024 * | 4.83B | Sales 2025 * | 5.1B | Capitalization | 19.58B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M | Net income 2025 * | -14M | EV / Sales 2024 * | 6.72 x |
| Net Debt 2024 * | 12.87B | Net Debt 2025 * | 13B | EV / Sales 2025 * | 6.39 x |
| P/E ratio 2024 * |
-217
x | P/E ratio 2025 * |
3,204
x | Employees | 486 |
| Yield 2024 * |
3.73% | Yield 2025 * |
3.94% | Free-Float | 99.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More press releases
More news
| 1 day | +0.21% | ||
| 1 week | -0.49% | ||
| Current month | +9.46% | ||
| 1 month | +12.38% | ||
| 3 months | +9.93% | ||
| 6 months | +8.43% | ||
| Current year | -2.75% |
1 week
48.21
49.10
1 month
42.8849.10
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 197 M€ | -.--% | ||
| 1.91% | 258 M€ | -1.97% | ||
| 1.43% | 133 M€ | +6.61% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-22 | 48.47 | +0.21% | 1,527,674 |
| 24-05-21 | 48.37 | -0.74% | 1,309,408 |
| 24-05-20 | 48.73 | -0.37% | 1,313,516 |
| 24-05-17 | 48.91 | +0.41% | 1,368,773 |
| 24-05-16 | 48.71 | 0.00% | 3,767,175 |
Delayed Quote Nyse, May 22, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
48.47
USD
Average target price
53.58
USD
Spread / Average Target
+10.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.75% | 19.58B | |
| +12.98% | 60.91B | |
| -1.41% | 13.74B | |
| +4.11% | 7.89B | |
| -7.31% | 5.99B | |
| +13.81% | 3.62B | |
| +0.35% | 3.32B | |
| -6.21% | 3.13B | |
| +0.81% | 2.97B | |
| +17.40% | 2.85B |
- Stock Market
- Equities
- VTR Stock
